<DOC>
	<DOCNO>NCT00642746</DOCNO>
	<brief_summary>The purpose study see alternate chemotherapy erlotinib increase tumor shrinkage people metastatic colorectal cancer . The investigator also study side effect ( good bad ) alternate chemotherapy erlotinib metastatic colorectal cancer .</brief_summary>
	<brief_title>Erlotinib Chemotherapy 2nd Line Treatment ( Tx ) Metastatic Colorectal Cancer ( mCRC )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Patients must fulfill follow criterion eligible study entry : Age 1880 Able provide inform consent Biopsy proven unresectable metastatic adenocarcinoma colon rectum Documented progression prior firstline oxaliplatinbased irinotecanbased regimen metastatic colorectal cancer Radiographically measurable disease least one bidimensionally measurable lesion &gt; 1 cm Prior firstline regimen must complete least 4 week prior study treatment Use biologic agent firstline chemotherapy permit Previous adjuvant regimen must great 6 month inclusion Adequate organ function include bone marrow , liver renal function define follow value : absolute neutrophil count &gt; 1500/microliter ; Hgb &gt; 9 g/dL ; platelet &gt; 90,000/microliter ; International Normalized Ratio &lt; 1.8 ( unless therapeutic range take warfarin warfarinderivative anticoagulant monitor regularly change prothrombin time International Normalized Ratio ) ; bilirubin &lt; 2 time Upper Limit Normal ; alkaline phosphatase &lt; 3 time Upper Limit Normal ; aspartate aminotransferase/alanine aminotransferase &lt; 5 time Upper Limit Normal ; serum creatinine &lt; 1.5 time Upper Limit Normal Eastern Cooperative Oncology Group status &lt; 2 Patients meeting follow criterion ineligible study entry : Prior secondline chemotherapy regimens colorectal cancer Prior treatment erlotinib gefitinib Central Nervous System metastasis Second malignancy less 5 year prior enrollment . Completely resect basal squamous cell carcinoma skin allow . Untreated/unresolved bowel obstruction Inability take oral mediation HIV positive Pregnancy Other uncontrolled medical illness Current diarrhea &gt; grade 2 Symptomatic angina uncontrolled congestive heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Colon</keyword>
	<keyword>Cancer</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Colorectal</keyword>
</DOC>